Kenvue CEO Discusses Growth Outlook After J&J Unit Jumps 20% in Market Debut
Johnson & Johnson's consumer-health unit Kenvue made its debut on the New York Stock Exchange and jumped about 20% on Thursday. Thibaut Mongon, CEO of Kenvue, joined Cheddar News to discuss business growth goals and what lies ahead for its well-known pipeline of products, including Band-Aid, Neutrogena, Tylenol, among others.
Depositors withdrew savings, and investors broadly sold off bank shares as the federal government raced to reassure Americans that the banking system is secure following two bank failures.
Pfizer has entered a $43 billion merger agreement with biotechnology firm Seagen in a deal designed to bolster the pharmaceutical giant's efforts to fight cancer
The second-largest stablecoin — a cryptocurrency that is pegged to a fiat currency — USCD depegged from the dollar, hitting an all-time low of around 88 cents over the weekend.
The Treasury Department, Federal Reserve, and Federal Deposit Insurance Corporation said all depositors at the failed Silicon Valley Bank could access all their money quickly, even as another major bank was shut down.
